A BILL 
To amend the Public Health Service Act to require group 
and individual health insurance coverage and group 
health plans to provide for cost sharing for oral 
anticancer drugs on terms no less favorable than the 
cost sharing provided for anticancer medications adminis-
tered by a health care provider. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
00:44 Mar 23, 2019
H1730
2 
•HR 1730 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Cancer Drug Parity 
2
Act of 2019’’. 
3
SEC. 2. PARITY IN COST SHARING FOR ORAL ANTICANCER 
4
DRUGS. 
5
(a) REQUIREMENT.— 
6
(1) IN GENERAL.—Section 2719A of the Public 
7
Health Service Act (42 U.S.C. 300gg–19a) is 
8
amended by adding at the end the following new 
9
subsection: 
10
‘‘(e) 
PARITY
IN
COST
SHARING
FOR
ORAL 
11
ANTICANCER DRUGS.— 
12
‘‘(1) IN GENERAL.—Subject to paragraph (2), a 
13
group health plan, and a health insurance issuer of-
14
fering group or individual health insurance coverage, 
15
that provides benefits with respect to anticancer 
16
medications administered by a health care provider 
17
shall provide that any cost sharing for prescribed, 
18
patient-administered anticancer medications that are 
19
used to kill, slow, or prevent the growth of cancerous 
20
cells and that have been approved by the Food and 
21
Drug Administration is no less favorable than the 
22
cost sharing for anticancer medications that is intra-
23
venously administered or injected by a health care 
24
provider. 
25
00:44 Mar 23, 2019
H1730
3 
•HR 1730 IH
‘‘(2) LIMITATION.—Paragraph (1) shall only 
1
apply to an anticancer medication that is prescribed 
2
based on a finding by the treating physician that the 
3
medication— 
4
‘‘(A) is medically necessary for the purpose 
5
of killing, slowing, or preventing the growth of 
6
cancerous cells; or 
7
‘‘(B) is clinically appropriate in terms of 
8
type, frequency, extent site, and duration. 
9
‘‘(3) RESTRICTION ON CERTAIN CHANGES.—A 
10
group health plan or health insurance issuer may 
11
not, in order to comply with the requirement of 
12
paragraph (1), make changes to benefits or replace 
13
existing benefits with new benefits under the plan or 
14
health insurance coverage designed to have the effect 
15
of— 
16
‘‘(A) imposing an increase in out-of-pocket 
17
costs with respect to anticancer medications; 
18
‘‘(B) reclassifying benefits with respect to 
19
anticancer medications in a way that would in-
20
crease such costs; or 
21
‘‘(C) applying more restrictive limitations 
22
on prescribed orally administered anticancer 
23
medications than on intravenously administered 
24
or injected anticancer medications. 
25
00:44 Mar 23, 2019
H1730
4 
•HR 1730 IH
‘‘(4) CONSTRUCTION.—Nothing in this sub-
1
section shall be construed— 
2
‘‘(A) to require the use of orally adminis-
3
tered anticancer medications as a replacement 
4
for other anticancer medications; 
5
‘‘(B) to prohibit a group health plan or 
6
health insurance issuer from requiring prior au-
7
thorization or imposing other appropriate utili-
8
zation controls in approving coverage for any 
9
chemotherapy; or 
10
‘‘(C) to supersede a State law that pro-
11
vides greater protections with respect to the 
12
coverage with respect to orally administered 
13
anticancer medications than is provided under 
14
this subsection. 
15
‘‘(5) COST
SHARING
DEFINED.—In this sub-
16
section, the term ‘cost sharing’ includes a deductible, 
17
coinsurance, copayment, and any maximum limita-
18
tion on the application of such a deductible, coinsur-
19
ance, copayment, and similar out-of-pocket ex-
20
penses.’’. 
21
(2) 
CONFORMING
AMENDMENT.—Section 
22
2724(c) of the Public Health Service Act (42 U.S.C. 
23
300gg–23(c)) is amended by striking ‘‘section 2704’’ 
24
and inserting ‘‘sections 2719A, 2725, and 2726’’. 
25
00:44 Mar 23, 2019
H1730
5 
•HR 1730 IH
(b) CLARIFYING AMENDMENT REGARDING APPLICA-
1
TION
TO
GRANDFATHERED
PLANS.—Section 
2
1251(a)(4)(A) of the Patient Protection and Affordable 
3
Care Act (42 U.S.C. 18011(a)(4)(A)) is amended by add-
4
ing at the end the following new clause: 
5
‘‘(v) Section 2719A(e) (relating to 
6
cost sharing for oral anticancer drugs).’’. 
7
(c) EFFECTIVE DATE.—The amendments made by 
8
this section shall apply with respect to group health plans 
9
for plan years beginning on or after January 1, 2020, and 
10
with respect to health insurance coverage offered, sold, 
11
issued, renewed, in effect, or operated in the individual 
12
or group market on or after such date. 
13
Æ 
00:44 Mar 23, 2019
H1730
